76 related articles for article (PubMed ID: 31122253)
21. [P16(INK4alpha)/Ki-67 immunocytochemical dual staining for detection of cervical lesions associated to papillomavirus infection].
Toro de Méndez M; Ferrández Izquierdo A; Llombart-Bosch A
Invest Clin; 2014 Sep; 55(3):238-48. PubMed ID: 25272523
[TBL] [Abstract][Full Text] [Related]
22. Implementation of p16/Ki67 dual stain cytology in a Danish routine screening laboratory: Importance of adequate training and experience.
Hammer A; Gustafson LW; Christensen PN; Brøndum R; Andersen B; Andersen RH; Tranberg M
Cancer Med; 2020 Nov; 9(21):8235-8242. PubMed ID: 32894896
[TBL] [Abstract][Full Text] [Related]
23. Automated detection of dual p16/Ki67 nuclear immunoreactivity in liquid-based Pap tests for improved cervical cancer risk stratification.
Gertych A; Joseph AO; Walts AE; Bose S
Ann Biomed Eng; 2012 May; 40(5):1192-204. PubMed ID: 22215277
[TBL] [Abstract][Full Text] [Related]
24. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.
Yoshida T; Fukuda T; Sano T; Kanuma T; Owada N; Nakajima T
Cancer; 2004 Apr; 102(2):100-8. PubMed ID: 15098254
[TBL] [Abstract][Full Text] [Related]
25. p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women.
Wentzensen N; Fetterman B; Castle PE; Schiffman M; Wood SN; Stiemerling E; Tokugawa D; Bodelon C; Poitras N; Lorey T; Kinney W
J Natl Cancer Inst; 2015 Dec; 107(12):djv257. PubMed ID: 26376685
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of p16INK4a as a diagnostic tool in the triage of Pap smears demonstrating atypical squamous cells of undetermined significance.
Duncan L; Jacob S; Hubbard E
Cancer; 2008 Feb; 114(1):34-48. PubMed ID: 18186493
[TBL] [Abstract][Full Text] [Related]
27. Utility of P16 expression and Ki-67 proliferation index in ASCUS and ASC-H pap tests.
Toll AD; Kelly D; Maleki Z
Diagn Cytopathol; 2014 Jul; 42(7):576-81. PubMed ID: 24288264
[TBL] [Abstract][Full Text] [Related]
28. P16 expression in relation to human papillomavirus in liquid-based cervical smears.
Samama B; Schaeffer C; Boehm N
Gynecol Oncol; 2008 May; 109(2):285-90. PubMed ID: 18387664
[TBL] [Abstract][Full Text] [Related]
29. Management of high-risk HPV-positive women for detection of cervical (pre)cancer.
Luttmer R; De Strooper LM; Steenbergen RD; Berkhof J; Snijders PJ; Heideman DA; Meijer CJ
Expert Rev Mol Diagn; 2016 Sep; 16(9):961-74. PubMed ID: 27459506
[TBL] [Abstract][Full Text] [Related]
30. Immunocytochemistry in liquid-based cervical cytology: analysis of clinical use following a cross-sectional study.
Sahebali S; Depuydt CE; Boulet GA; Arbyn M; Moeneclaey LM; Vereecken AJ; Van Marck EA; Bogers JJ
Int J Cancer; 2006 Mar; 118(5):1254-60. PubMed ID: 16161049
[TBL] [Abstract][Full Text] [Related]
31. A pre-tailored panel of antibodies in the study of cervical mesonephric remnants.
Pavlakis K; Messini I; Yiannou P; Chrissanthakis D; Papaspyrou I; Panoskaltsis T; Stathopoulos EN
Gynecol Oncol; 2010 Mar; 116(3):468-72. PubMed ID: 19913894
[TBL] [Abstract][Full Text] [Related]
32. Establishing a protocol for immunocytochemical staining and chromogenic in situ hybridization of Giemsa and Diff-Quick prestained cytological smears.
Beraki E; Olsen TK; Sauer T
Cytojournal; 2012; 9():8. PubMed ID: 22574078
[TBL] [Abstract][Full Text] [Related]
33. The impact of the COVID-19 pandemic on organised cervical cancer screening: The first results of the Slovenian cervical screening programme and registry.
Ivanuš U; Jerman T; Gašper Oblak U; Meglič L; Florjančič M; Strojan Fležar M; Premru Sršen T; Smrkolj Š; Pakiž M; Primic Žakelj M; Kloboves Prevodnik V; Pogačnik A; Josipović I; Mate T; Gobec M
Lancet Reg Health Eur; 2021 Jun; 5():100101. PubMed ID: 34557821
[TBL] [Abstract][Full Text] [Related]
34. A Scoring Method for Immunohistochemical Staining on Ki67.
Guo R; Ma L; Bai X; Miao L; Li Z; Yang J
Appl Immunohistochem Mol Morphol; 2021 Mar; 29(3):e20-e28. PubMed ID: 32287078
[TBL] [Abstract][Full Text] [Related]
35. Validation and Implementation of OptiView and EnVision FLEX Detection Systems for Immunocytochemical Staining Protocols of the Ten Most Commonly Used Diagnostic Markers in Routine Cytopathological Practice.
Dremelj A; Miceska S; Kuhar A; Nolde N; Kloboves-Prevodnik V
Diagnostics (Basel); 2024 Mar; 14(6):. PubMed ID: 38535077
[TBL] [Abstract][Full Text] [Related]
36. Classification of cervical biopsy free-text diagnoses through linear-classifier based natural language processing.
Hsu JW; Christensen P; Ge Y; Long SW
J Pathol Inform; 2022; 13():100123. PubMed ID: 36268101
[TBL] [Abstract][Full Text] [Related]
37. Correlation Analysis of Ultrasound Elastography Score with Invasive Breast Cancer and Biological Prognostic Factors.
Fu Q; Wan F; Lu Q; Shao W; Fu G; Wang Z
Contrast Media Mol Imaging; 2022; 2022():1174541. PubMed ID: 35873667
[TBL] [Abstract][Full Text] [Related]
38. False Negative Results in Cervical Cancer Screening-Risks, Reasons and Implications for Clinical Practice and Public Health.
Macios A; Nowakowski A
Diagnostics (Basel); 2022 Jun; 12(6):. PubMed ID: 35741319
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic performance of p16/Ki-67 dual immunostaining at different number of positive cells in cervical smears in women referred for colposcopy.
Gajsek US; Dovnik A; Takac I; Ivanus U; Jerman T; Zatler SS; Fokter AR
Radiol Oncol; 2021 Nov; 55(4):426-432. PubMed ID: 34821133
[TBL] [Abstract][Full Text] [Related]
40. Novel biomarkers with promising benefits for diagnosis of cervical neoplasia: a systematic review.
Onyango CG; Ogonda L; Guyah B; Shiluli C; Ganda G; Orang'o OE; Patel K
Infect Agent Cancer; 2020 Nov; 15(1):68. PubMed ID: 33292364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
